Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F8N5D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,547
Award facts
- Contract value 100% obligated
- $37,546.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,546.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet bottles of Eliquis 5 mg tablets, with an ultimate completion date of January 8, 2026. The award, issued on January 7, 2026, represents a non-set-aside competitive award and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.999 billion global pharmaceutical supply vehicle through December 2026 that enables the company to deliver medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio demonstrates capability across multiple therapeutic domains, with this Eliquis order supporting the broader pharmaceutical supply needs of the Defense Health Agency and other government healthcare systems. As a primary vendor under DLA's pharmaceutical supply chain infrastructure, AmerisourceBergen competes on a full and open basis and maintains the operational capacity to efficiently fulfill government requirements for essential prescription medications and medical commodities.
Quick answers
Who was awarded contract SPE2DR26F8N5D?
SPE2DR26F8N5D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F8N5D worth?
The government has obligated $37,547 on SPE2DR26F8N5D.
Is contract SPE2DR26F8N5D an order under another contract?
Yes. SPE2DR26F8N5D is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N5D competed?
The extent of competition for SPE2DR26F8N5D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award